Cargando…
Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression
OBJECTIVE: Roux-en-Y gastric bypass surgery (RYGB) improves the first phase of glucose-stimulated insulin secretion (GSIS) in patients with type 2 diabetes. How it does so remains unclear. Farnesoid X receptor (FXR), the nuclear receptor of bile acids (BAs), is implicated in bariatric surgery. Moreo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728758/ https://www.ncbi.nlm.nih.gov/pubmed/31668381 http://dx.doi.org/10.1016/j.molmet.2019.08.009 |
_version_ | 1783449475202678784 |
---|---|
author | Kong, Xiangchen Tu, Yifan Li, Bingfeng Zhang, Longmei Feng, Linxian Wang, Lixiang Zhang, Lin Zhou, Huarong Hua, Xianxin Ma, Xiaosong |
author_facet | Kong, Xiangchen Tu, Yifan Li, Bingfeng Zhang, Longmei Feng, Linxian Wang, Lixiang Zhang, Lin Zhou, Huarong Hua, Xianxin Ma, Xiaosong |
author_sort | Kong, Xiangchen |
collection | PubMed |
description | OBJECTIVE: Roux-en-Y gastric bypass surgery (RYGB) improves the first phase of glucose-stimulated insulin secretion (GSIS) in patients with type 2 diabetes. How it does so remains unclear. Farnesoid X receptor (FXR), the nuclear receptor of bile acids (BAs), is implicated in bariatric surgery. Moreover, the transient receptor potential ankyrin 1 (TRPA1) channel is expressed in pancreatic β-cells and involved in insulin secretion. We aimed to explore the role of BAs/FXR and TRPA1 in improved GSIS in diabetic rats after RYGB. METHODS: RYGB or sham surgery was conducted in spontaneous diabetic Goto-Kakizaki (GK) rats, or FXR or TRPA1 transgenic mice. Gene and protein expression of islets were assessed by qPCR and western blotting. Electrophysiological properties of single β-cells were studied using patch-clamp technique. Binding of FXR and histone acetyltransferase steroid receptor coactivator-1 (SRC1) to the TRPA1 promoter, acetylated histone H3 (ACH3) levels at the TRPA1 promoter were determined using ChIP assays. GSIS was measured using enzyme-linked immunosorbent assays or intravenous glucose tolerance test (IVGTT). RESULTS: RYGB increases GSIS, particularly the first-phase of GSIS in both intact islets and GK rats in vivo, and ameliorates hyperglycemia of GK rats. Importantly, the effects of RYGB were attenuated in TRPA1-deficient mice. Moreover, GK β-cells displayed significantly decreased TRPA1 expression and current. Patch-clamp recording revealed that TRPA1(−/−) β-cells displayed a marked hyperpolarization and decreased glucose-evoked action potential firing, which was associated with impaired GSIS. RYGB restored TRPA1 expression and current in GK β-cells. This was accompanied by improved glucose-evoked electrical activity and insulin secretion. Additionally, RYGB-induced TRPA1 expression involved BAs/FXR-mediated recruitment of SRC1, promoting ACH3 at the promoter of TRPA1. CONCLUSIONS: The BAs/FXR/SRC1 axis-mediated restoration of TRPA1 expression plays a critical role in the enhanced GSIS and remission of diabetes in GK rats after RYGB. |
format | Online Article Text |
id | pubmed-6728758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-67287582019-09-12 Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression Kong, Xiangchen Tu, Yifan Li, Bingfeng Zhang, Longmei Feng, Linxian Wang, Lixiang Zhang, Lin Zhou, Huarong Hua, Xianxin Ma, Xiaosong Mol Metab Original Article OBJECTIVE: Roux-en-Y gastric bypass surgery (RYGB) improves the first phase of glucose-stimulated insulin secretion (GSIS) in patients with type 2 diabetes. How it does so remains unclear. Farnesoid X receptor (FXR), the nuclear receptor of bile acids (BAs), is implicated in bariatric surgery. Moreover, the transient receptor potential ankyrin 1 (TRPA1) channel is expressed in pancreatic β-cells and involved in insulin secretion. We aimed to explore the role of BAs/FXR and TRPA1 in improved GSIS in diabetic rats after RYGB. METHODS: RYGB or sham surgery was conducted in spontaneous diabetic Goto-Kakizaki (GK) rats, or FXR or TRPA1 transgenic mice. Gene and protein expression of islets were assessed by qPCR and western blotting. Electrophysiological properties of single β-cells were studied using patch-clamp technique. Binding of FXR and histone acetyltransferase steroid receptor coactivator-1 (SRC1) to the TRPA1 promoter, acetylated histone H3 (ACH3) levels at the TRPA1 promoter were determined using ChIP assays. GSIS was measured using enzyme-linked immunosorbent assays or intravenous glucose tolerance test (IVGTT). RESULTS: RYGB increases GSIS, particularly the first-phase of GSIS in both intact islets and GK rats in vivo, and ameliorates hyperglycemia of GK rats. Importantly, the effects of RYGB were attenuated in TRPA1-deficient mice. Moreover, GK β-cells displayed significantly decreased TRPA1 expression and current. Patch-clamp recording revealed that TRPA1(−/−) β-cells displayed a marked hyperpolarization and decreased glucose-evoked action potential firing, which was associated with impaired GSIS. RYGB restored TRPA1 expression and current in GK β-cells. This was accompanied by improved glucose-evoked electrical activity and insulin secretion. Additionally, RYGB-induced TRPA1 expression involved BAs/FXR-mediated recruitment of SRC1, promoting ACH3 at the promoter of TRPA1. CONCLUSIONS: The BAs/FXR/SRC1 axis-mediated restoration of TRPA1 expression plays a critical role in the enhanced GSIS and remission of diabetes in GK rats after RYGB. Elsevier 2019-08-15 /pmc/articles/PMC6728758/ /pubmed/31668381 http://dx.doi.org/10.1016/j.molmet.2019.08.009 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Kong, Xiangchen Tu, Yifan Li, Bingfeng Zhang, Longmei Feng, Linxian Wang, Lixiang Zhang, Lin Zhou, Huarong Hua, Xianxin Ma, Xiaosong Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression |
title | Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression |
title_full | Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression |
title_fullStr | Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression |
title_full_unstemmed | Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression |
title_short | Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression |
title_sort | roux-en-y gastric bypass enhances insulin secretion in type 2 diabetes via fxr-mediated trpa1 expression |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728758/ https://www.ncbi.nlm.nih.gov/pubmed/31668381 http://dx.doi.org/10.1016/j.molmet.2019.08.009 |
work_keys_str_mv | AT kongxiangchen rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression AT tuyifan rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression AT libingfeng rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression AT zhanglongmei rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression AT fenglinxian rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression AT wanglixiang rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression AT zhanglin rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression AT zhouhuarong rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression AT huaxianxin rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression AT maxiaosong rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression |